HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Perrin, L. H. Articles by Oldstone, M. B. A. Search for Related Content PubMed Articles by Perrin, L. H. Articles by Oldstone, M. B. A.

The Formation and Fate of Virus Antigen-Antibody Complexes¹

From the Department of Immunopathology, Scripps Clinic and Research Foundation, La Jolla, California 92037

Abstract

We report the fate of ¹²⁵I human IgG measles virus antibodies complexed to virus antigens expressed on the surfaces of HeLa cells persistently infected with measles virus. Each HeLa cell expressing viral antigens on its surface bound about 7.5 x 10⁶ IgG molecules under saturation conditions. Three hours after ¹²⁵I antiviral IgG bound to and saturated all antigenic sites on infected cells, 30% of the counts were released (85% TCA ppt), after 12 hr 60%, and after 24 hr 75% (30% TCA ppt). By linear sucrose density centrifugation about 30% of the counts released from infected cells at 3 hr sedimented faster than 7S IgG, 60% sedimented at the 7S position whereas 10% (non-TCA ppt) were found at the top of the gradient. Using specific rabbit antibody to measles virus hemagglutinin or nucleocapsid, we found that hemagglutinin, but not nucleocapsid antigen, was present in the heavy complexes. These experiments show that after anti-measles virus antibody binds to cell surface measles viral antigens (i.e., hemagglutinin), immune complexes form and are shed into culture fluids. In addition part of the immune complex is endocytosed and broken into small m.w. components. Shedding of virus antigen-antibody complexes from the cell's surface may be an important source of the circulating complexes found in virus-infected humans and animals.

Footnotes

¹ This is publication No. 1187 from the Department of Immunopathology, Scripps Clinic and Research Foundation, La Jolla, California 92037. This research was supported by United States Public Health Service Grants NS-12428, AI-07007 and AI-09484.

² Dr. Perrin is supported by a fellowship from the Swiss National Research Foundation.